TESARO to Present at the 32nd Annual J.P. Morgan Healthcare Conference

        Print
| Source: TESARO, Inc.

WALTHAM, Mass., Jan. 7, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will attend the 32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. Mr. Moulder will make a presentation at the conference on Thursday, January 16, 2014 at 1:30 p.m. Pacific time.

A live webcast will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

Jennifer Davis
Sr. Director, Corporate Development & Investor Relations
1.781.325.1116